On December 20, 2024, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. AASM.org Among persons with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the AHI, body weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes. NIH study Can the makers of these new weight loss medications really claim to treat and cure Obstructive Sleep Apnea (OSA)
Mold triggers something called the cell danger response (CDR)
After veterinary evaluation, consumption of vitamin b12 injection makes mental health better
doi:10.3928/01477447-20151222-12 Carender CN, Glass NA, DeMik DE, Elkins JM, Brown TS, Bedard NA
It typically takes a few days to a couple of weeks for the soreness of the razor throat to improve
If denied, file a formal appeal through TennCare's managed care organization